HRT Financial’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-107,198
Closed -$45K – 5048
2026
Q2
$45K Buy
+107,198
New +$74.2K ﹤0.01% 3795
2023
Q4
– Sell
-1,521
Closed -$8K – 2518
2023
Q3
$8K Buy
+1,521
New +$13.3K ﹤0.01% 2140
2022
Q1
– Sell
-1,345
Closed -$22K – 3298
2021
Q4
$22K Buy
+1,345
New +$30.5K ﹤0.01% 2938
2021
Q2
– Sell
-1,504
Closed -$75K – 3022
2021
Q1
$75K Buy
+1,504
New +$93.1K ﹤0.01% 2492

Other funds holding EVGN

HRT Financial's EVGN Position: Q3 2026 in Review

HRT Financial sold out of Evogene (EVGN) in Q3 2026, closing a stake of 107,198 shares — an estimated $45K sold.

HRT Financial first reported a position in EVGN in Q1 2021 and held it in 4 quarters. The position peaked at $75K in Q1 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q3 2026.

  • HRT Financial reported no remaining Evogene position as of Q3 2026 after selling out during the quarter.
  • HRT Financial sold 107,198 Evogene shares in Q3 2026, an estimated $45K.
  • HRT Financial first reported a position in Evogene in Q1 2021 and held it in 4 quarters.
  • HRT Financial's Evogene position peaked at $75K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.